Cytosorbents (CTSO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Cytosorbents Revenue Highlights

Latest Revenue (Y)

$36.35M

Latest Revenue (Q)

$8.61B

Main Segment (Y)

Grant income

Main Geography (Y)

All other countries

Cytosorbents Revenue by Period

Cytosorbents Revenue by Year

Date	Revenue	Change
2023-12-31	$36.35M	23.81%
2022-12-31	$29.36M	-26.80%
2021-12-31	$40.11M	1.66%
2020-12-31	$39.45M	73.30%
2019-12-31	$22.77M	12.41%
2018-12-31	$20.25M	51.34%
2017-12-31	$13.38M	63.07%
2016-12-31	$8.21M	102.33%
2015-12-31	$4.06M	28.96%
2014-12-31	$3.15M	282.70%
2013-12-31	$821.79K	442.17%
2012-12-31	$151.57K	320.13%
2011-12-31	$36.08K	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	-100.00%
2005-05-31	$10.00K	-

Cytosorbents generated $36.35M in revenue during NA 2023, up 23.81% compared to the previous quarter, and up 179.48% compared to the same period a year ago.

Cytosorbents Revenue by Quarter

Date	Revenue	Change
2024-09-30	$8.61B	86945.09%
2024-06-30	$9.89M	1.11%
2024-03-31	$9.79M	12.90%
2023-12-31	$8.67M	11.79%
2023-09-30	$7.75M	-3.94%
2023-06-30	$8.07M	2.05%
2023-03-31	$7.91M	3.51%
2022-12-31	$7.64M	18.25%
2022-09-30	$6.46M	-11.84%
2022-06-30	$7.33M	-7.49%
2022-03-31	$7.92M	-18.29%
2021-12-31	$9.70M	8.94%
2021-09-30	$8.90M	-21.68%
2021-06-30	$11.37M	12.05%
2021-03-31	$10.14M	-12.03%
2020-12-31	$11.53M	12.54%
2020-09-30	$10.25M	7.62%
2020-06-30	$9.52M	16.73%
2020-03-31	$8.16M	23.38%
2019-12-31	$6.61M	15.40%
2019-09-30	$5.73M	-2.09%
2019-06-30	$5.85M	27.83%
2019-03-31	$4.58M	-16.35%
2018-12-31	$5.47M	7.21%
2018-09-30	$5.10M	-2.72%
2018-06-30	$5.25M	18.32%
2018-03-31	$4.43M	3.19%
2017-12-31	$4.30M	24.57%
2017-09-30	$3.45M	13.41%
2017-06-30	$3.04M	17.14%
2017-03-31	$2.60M	-0.64%
2016-12-31	$2.61M	21.92%
2016-09-30	$2.14M	15.68%
2016-06-30	$1.85M	15.98%
2016-03-31	$1.60M	6.81%
2015-12-31	$1.50M	39.58%
2015-09-30	$1.07M	36.62%
2015-06-30	$784.28K	11.33%
2015-03-31	$704.49K	-19.36%
2014-12-31	$873.65K	-15.53%
2014-09-30	$1.03M	55.36%
2014-06-30	$665.73K	16.61%
2014-03-31	$570.91K	81.73%
2013-12-31	$314.16K	54.33%
2013-09-30	$203.56K	59.07%
2013-06-30	$127.97K	-27.33%
2013-03-31	$176.10K	-130.00%
2012-12-31	$-587.04K	-196.98%
2012-09-30	$605.35K	1732.05%
2012-06-30	$33.04K	95.60%
2012-03-31	$16.89K	-53.18%
2011-12-31	$36.08K	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Cytosorbents generated $8.61B in revenue during Q3 2024, up 86945.09% compared to the previous quarter, and up 106694.19% compared to the same period a year ago.

Cytosorbents Revenue Breakdown

Cytosorbents Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Grant income	$5.26M	-	-	-	-
Other sales	$69.69K	$787.20K	-	-	-
Cyto Sorb Sales	-	-	$40.00M	$39.34M	$22.55M
Other Sales	-	-	$111.87K	$110.40K	$220.10K

Cytosorbents's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant income (98.69%), and Other sales (1.31%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Grant income	$777.59K	$1.05M	$796.77K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other sales	$26.52K	$11.40K	$24.73K	$59.33K	$6.58K	$3.77K	$245.51K	$191.47K	$292.63K	-	-	-	-	-	-	-	-	-	-	-
Cyto Sorb Sales	-	-	-	-	-	-	-	-	$7.04M	$7.87M	$9.59M	$8.90M	$11.36M	$10.14M	$11.49M	$10.25M	$9.45M	$8.16M	$6.54M	$5.65M
Other product sales	-	-	-	-	-	-	-	-	-	$57.59K	-	-	-	-	-	-	-	-	-	-
Other Sales	-	-	-	-	-	-	-	-	-	-	$106.29K	$797.00	$4.78K	$41.40K	-	$69.00K	-	$73.30K	$80.00K	-

Cytosorbents's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant income (96.70%), and Other sales (3.30%).

Cytosorbents Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Germany	$12.96M	-	-	-	-
United States	$5.26M	$968.95K	$1.69M	-	-
All other countries	$18.05M	$15.82M	$17.41M	-	-
All Other Countries	-	-	-	$17.85M	$8.15M
D	-	-	-	-	-
U	-	-	-	$1.34M	$2.18M

Cytosorbents's latest annual revenue breakdown by geography, as of Dec 23: All other countries (49.76%), Germany (35.73%), and United States (14.51%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Germany	$3.18M	$2.78M	$3.54M	$6.46M	$3.17M	$3.34M	$2.49M	$2.98M	$3.78M	$5.33M	$3.66M	-	-	-	-	-	-	-	-	-
United States	$777.59K	$1.05M	$796.77K	$2.38M	$1.35M	$1.54M	$1.75M	$200.47K	$310.63K	$212.34K	$446.74K	$577.45K	-	-	-	-	-	-	-	-
All other countries	$5.41M	$6.02M	$5.41M	$8.59M	$4.90M	$4.57M	$3.77M	$4.04M	$3.93M	$3.92M	$4.66M	-	-	-	-	-	-	-	-	-
All Other Countries	-	-	-	-	-	-	-	-	-	-	-	-	$4.88M	$3.94M	$5.20M	$5.17M	$4.25M	$3.24M	$2.38M	$2.20M
U	-	-	-	-	-	-	-	-	-	-	-	-	$362.03K	$455.49K	$344.20K	$261.50K	$274.57K	$551.34K	$819.92K	$366.54K
D	-	-	-	-	-	-	-	-	-	-	-	-	$6.12M	$5.90M	$5.99M	-	-	-	$4.15M	-

Cytosorbents's latest quarterly revenue breakdown by geography, as of Sep 24: All other countries (57.75%), Germany (33.95%), and United States (8.30%).

Cytosorbents Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LIVN	LivaNova	$1.15B	$318.11M
AORT	Artivion	$354.00M	$95.78M
INGN	Inogen	$315.66M	$88.83M
FNA	Paragon 28	$216.39M	$61.02M
KIDS	OrthoPediatrics	$148.73M	$52.80M
SRDX	Surmodics	$126.08M	$30.34M
LUNG	Pulmonx	$68.67M	$20.39M
NPCE	NeuroPace	$65.42M	$21.06M
TELA	TELA Bio	$58.45M	$18.96M
APYX	Apyx Medical	$52.35M	$16.02M
CVRX	CVRx	$39.30M	$13.37M
CTSO	Cytosorbents	$36.35M	$8.61B
CLPT	ClearPoint Neuro	$23.95M	$8.12M
OFIX	Orthofix Medical	$100.00K	$198.62M

CTSO Revenue FAQ

What is Cytosorbents’s yearly revenue?

Cytosorbents's yearly revenue for 2023 was $36.35M, representing an increase of 23.81% compared to 2022. The company's yearly revenue for 2022 was $29.36M, representing a decrease of -26.80% compared to 2021. CTSO's yearly revenue for 2021 was $40.11M, representing an increase of 1.66% compared to 2020.

What is Cytosorbents’s quarterly revenue?

Cytosorbents's quarterly revenue for Q3 2024 was $8.61B, a 86945.09% increase from the previous quarter (Q2 2024), and a 110975.51% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $9.89M, a 1.11% increase from the previous quarter (Q1 2024), and a 22.57% increase year-over-year (Q2 2023). CTSO's quarterly revenue for Q1 2024 was $9.79M, a 12.90% increase from the previous quarter (Q4 2023), and a 23.72% increase year-over-year (Q1 2023).

What is Cytosorbents’s revenue growth rate?

Cytosorbents's revenue growth rate for the last 3 years (2021-2023) was -9.37%, and for the last 5 years (2019-2023) was 59.67%.

What are Cytosorbents’s revenue streams?

Cytosorbents's revenue streams in c 23 are Grant income, and Other sales. Grant income generated $5.26M in revenue, accounting 98.69% of the company's total revenue Other sales generated $69.68K in revenue, accounting 1.31% of the company's total revenue, down -91.15% year-over-year.

What is Cytosorbents’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cytosorbents was Grant income. This segment made a revenue of $5.26M, representing 98.69% of the company's total revenue.